Skip to content
value.today

Oculogica, Inc.

🇺🇸 New York, New York, USABiotechnologyFounded 2013
Total raised
$21 M
4 rounds on record
Latest round
$8 M
Apr 2024
First round on record
Mar 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Oculogica, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2024$8 MNo. 4$2 to $10 million

Oculogica, Inc.: Raise no. 4, Apr 2024

Investors in this round

24 investors had bought by the notice of May 13, 2024: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $18 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rosina Samadani · Executive Officer, Director
  • Jill Enos · Director
  • Jim Flannigan · Director
  • Kathryn Swintek · Director
  • Pratipatti Laxminarain · Director
  • Uzma Samadani · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rosina Samadani, Chief Executive Officer. Source: SEC Form D, newest notice filed May 13, 2024. Read the notice at the SEC.

equitySEC
Mar 2022$4 MNo. 3$2 to $10 million

Oculogica, Inc.: Raise no. 3, Mar 2022

Investors in this round

20 investors had bought by the notice of Jun 23, 2022: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rosina Samadani · Executive Officer, Director
  • Jill Enos · Director
  • Kathryn Swintek · Director
  • Pratipatti Laxminarain · Director
  • Uzma Samadani · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rosina Samadani, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 23, 2022. Read the notice at the SEC.

equity, debtSEC
Dec 2019$8 MNo. 2$2 to $10 million

Oculogica, Inc.: Raise no. 2, Dec 2019

Investors in this round

41 investors had bought by the notice of Jan 3, 2020: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $9 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rosina Samadani · Executive Officer, Director
  • Jill Enos · Director
  • Kathryn Swintek · Director
  • Pratipatti Laxminarain · Director
  • Uzma Samadani · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rosina Samadani, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 3, 2020. Read the notice at the SEC.

equitySEC
Mar 2016$2 MNo. 1Under $2 million

Oculogica, Inc.: Raise no. 1, Mar 2016

Investors in this round

8 investors had bought by the notice of Mar 17, 2016: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rosina Samadani · Executive Officer
  • Bilal Khan · Director
  • Jason Huang · Director
  • Uzma Samadani · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Some of the proceeds may be used for general working capital purposes including payment of salaries and other fees to those listed in Item 3.”

Signed by Rosina Samadani, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 17, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Oculogica, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2024

That is all the official record says: Oculogica, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Oculogica, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 41 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Oculogica, Inc.
NameRoleNamed in
Rosina SamadaniExecutive officerMay 2024
Jill EnosDirectorMay 2024
Jim FlanniganDirectorMay 2024
Kathryn SwintekDirectorMay 2024
Pratipatti LaxminarainDirectorMay 2024
Rosina SamadaniDirectorMay 2024
Uzma SamadaniDirectorMay 2024
Bilal KhanDirectorMar 2016
Jason HuangDirectorMar 2016